National Foundation for Cancer Research Revenue and Competitors

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • National Foundation for Cancer Research's estimated annual revenue is currently $3.5M per year.(i)
  • National Foundation for Cancer Research's estimated revenue per employee is $63,636

Employee Data

  • National Foundation for Cancer Research has 55 Employees.(i)
  • National Foundation for Cancer Research grew their employee count by 10% last year.

National Foundation for Cancer Research's People

NameTitleEmail/Phone
1
Executive Director & Chief StaffReveal Email/Phone
2
Major Gifts OfficerReveal Email/Phone
3
Director DevelopmentReveal Email/Phone
4
Digital Marketing ManagerReveal Email/Phone
5
Marketing and Communication SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2567%N/AN/A
#2
$15M1948%N/AN/A
#3
$35M743%N/AN/A
#4
N/A3210%N/AN/A
#5
$7.5M637%N/AN/A
#6
N/A6215%N/AN/A
#7
N/A3-25%N/AN/A
#8
$3.5M29-9%N/AN/A
#9
$15M2226%N/AN/A
#10
$15M8228%N/AN/A
Add Company

What Is National Foundation for Cancer Research?

Research for a Cure Since 1973, the National Foundation for Cancer Research (NFCR) has funded scientific discoveries, medical advancements and changes in technology that have revolutionized the way doctors treat all types of cancer. NFCR has long been a catalyst for the invention of the kinds of "disruptive innovations" that are bringing hope and promise to patients suffering with cancer. Our focus has always been to provide scientists with the adventure funding to research, discover and then incubate their novel ideas, programs and products. Yesterday’s discoveries led to today’s treatments – and today’s research will lead to tomorrow’s cures. NFCR-funded scientists continue to make remarkable advances in the fight against cancer. 2016 research highlights in the fight against cancer include: * Blood tests to detect the spread of cancer * Earlier detection of ovarian cancer * New treatments to combat drug resistance in lung cancer * And much more! The generous support of our donors has made these scientific advancements possible. To date, NFCR has delivered more than $350 million in funding to cancer research leading to numerous breakthroughs, including prevention strategies, earlier diagnostic techniques, and new anticancer drugs and therapies.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$3.5M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A5528%N/A
#2
$8.1M550%N/A
#3
$14.4M5512%N/A
#4
$7.4M556%N/A
#5
$15.5M560%N/A